Showing results (141-150 of 226) with videos related to

Sort By:
Pageof 23
Blood Advances|March 19, 2024
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysisJulia Driessen, Fer de Wit, Alex F Herrera, et al.
Scientific Reports|August 12, 2023
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patientsMaria C Ferrández, Sandeep S V Golla, Jakoba J Eertink, et al.
BMJ Open|September 13, 2018
Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA)Inge M Krul, Annemieke W J Opstal-van Winden, Josée M Zijlstra, et al.
The Journal of Infectious Diseases|July 25, 2024
Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T CellsNienke H van Teijlingen, Marleen Y van Smoorenburg, Ramin Sarrami-Forooshani, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18F-Fluorodeoxyglucose and 89Zr-Rituximab PET ScansBart M de Vries, Sandeep S V Golla, Gerben J C Zwezerijnen, et al.
British Journal of Cancer|June 21, 2017
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivorsAnna M van Eggermond, Michael Schaapveld, Cécile Pm Janus, et al.
Health Informatics Journal|January 28, 2023
Incomplete patient information exchange and unnecessary repeat diagnostics during oncological referrals in the Netherlands: exploring the role of information exchangeMerijn E De Swart, Barbara M Zonderhuis, Tessa Hellingman, et al.
Haematologica|May 15, 2025
Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET responseJakoba J Eertink, Martijn W Heymans, Sanne E Wiegers, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 6, 2014
Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphomaAntoinette de Jong, Thomas C Kwee, John M H de Klerk, et al.
Blood|September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphomaCarsten Kobe, Markus Dietlein, Jeremy Franklin, et al.
Pageof 23